Read More Pharma Industry News IHL-42X screening begins as Incannex Healthcare enters a faster-moving oral sleep apnea race Incannex Healthcare begins IHL-42X screening as cash, buybacks and Apnimed’s FDA filing reshape the oral sleep apnea investment case. bySoujanya RaviJuly 27, 2026